Construction of PANoptosis-Inhibiting Carbonized Polymer Dots via Machine Learning Potential for Mitigating

Xinchen Liu1, Jiaxin Zhang2, Xiangyu Yan3

  • 1Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, 130021, P. R. China.

Insights

New bioactive carbonized polymer dots (Lu-CDs) inhibit PANoptosis, a cell death pathway, offering superior protection against chemotherapy-induced acute kidney injury (AKI) in mice.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Pharmacology

Background:

  • Chemotherapy can cause acute kidney injury (AKI) via regulated cell death (RCD) pathways.
  • Current treatments focus on apoptosis inhibition and oxidative stress, but a multi-mechanistic approach is needed.
  • PANoptosis, a novel RCD pathway, presents a new therapeutic target for nephroprotection.

Purpose of the Study:

  • To develop novel bioactive carbonized polymer dots (Lu-CDs) for enhanced nephroprotection.
  • To investigate the efficacy of Lu-CDs in mitigating chemotherapy-induced AKI.
  • To explore PANoptosis inhibition as a strategy against drug-induced kidney damage.

Main Methods:

  • Utilized enhanced sampling with machine learning force fields for molecular dynamics to design Lu-CDs.
  • Incorporated flavonoid pharmacophores into Lu-CDs for dual radical scavenging and PANoptosis-inhibiting activities.
  • Evaluated Lu-CDs' nephroprotective effects in a mouse model of chemotherapy-induced AKI.

Main Results:

  • Lu-CDs exhibited both radical scavenging and PANoptosis-inhibiting properties, unlike conventional antioxidative carbonized polymer dots.
  • A low dose of Lu-CDs demonstrated prolonged renal accumulation and superior nephroprotective efficacy in mice.
  • Lu-CDs outperformed both small-molecule flavonoids and antioxidative carbonized polymer dots in preventing AKI.

Conclusions:

  • Machine learning-guided design of nanodrugs offers a promising strategy for targeted therapy.
  • PANoptosis inhibition is an effective approach to combat chemotherapy-induced nephrotoxicity.
  • Lu-CDs represent a novel therapeutic candidate for preventing AKI.

Related Concept Videos